Gothenburg, Sweden – Captario, the life science SaaS-platform decision analytics company, announces the launch of Professional Services to further enable strategic decision-making throughout the drug development process.
The Captario proprietary SaaS-platform, Captario SUM® (Strategic Uncertainty Management), is a purpose-built decision analytics tool developed by former pharma professionals who saw a need for proactive, faster, and informed business decisions. Through the use of the Captario SUM® tool, customers can model an end-to-end drug development cycle, account for developmental uncertainty, have access to real-time insights across functional silos, and run countless what-if simulations in a sandbox environment that enables superior decision-making.
Customers now have access to the just launched Professional Services, which serve as extensions of the already existing Captario SUM® subscription, and are being offered in two separate ways:
”It has always been our mission to make a major step-change in decision-making within pharma – and that’s what SUM® does today. With a talented team that hold a variety of of essential competencies such as advanced statistics, applied mathematics, data analytics, and decision theory, we feel confident that our Professional Services offering will further expand our ability to collaborate individually with customers and answer their most pressing and complex development questions.”
The Captario Professional Services offering span the entire drug development life cycle from early-stage to late-stage product and portfolio needs, and can help answer questions such as:
"The partnership with Captario has, since the beginning with a Proof of Concept, been outstanding… we only wish we had more vendor partnerships like this!"
Read press release here.
Comments are closed.